APO Research
Talk to an analyst

APO RESEARCH · REPORT

Digital Pathology Scanner and Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Digital Pathology Scanner and Software Market Analysis and Forecast 2026-2032

3 May 2026245 pages

Choose your research edition.

Industry ResearchDigital Pathology Scanner and Software Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Digital Pathology Scanner and Software Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Digital Pathology Scanner and Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digital Pathology Scanner and Software Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Digital Pathology Scanner and Software Market Analysis and Forecast 2026-2032245 pages · $4,950 USD

Market perspective

The global Digital Pathology Scanner and Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Digital Pathology Scanner and Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Digital Pathology Scanner and Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Digital Pathology Scanner and Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Digital Pathology Scanner and Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Digital Pathology Scanner and Software include Danaher Corporation, Fujifilm, Philips Healthcare, Mikroscan, 3DHISTECH, PathAI, Roche, Hamamatsu Photonics and Apollo Enterprise Imaging, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Digital Pathology Scanner and Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Digital Pathology Scanner and Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Digital Pathology Scanner and Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Digital Pathology Scanner and Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Digital Pathology Scanner and Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Digital Pathology Scanner and Software revenue, projected growth trends, production technology, application and end-user industry.

Digital Pathology Scanner and Software Segment by Company

Danaher Corporation

Fujifilm

Philips Healthcare

Mikroscan

3DHISTECH

PathAI

Roche

Hamamatsu Photonics

Apollo Enterprise Imaging

XIFIN

KFBIO

Aiforia

Glencoe Software

Digital Pathology Scanner and Software Segment by Type

Scanner

Software

Digital Pathology Scanner and Software Segment by Application

Hospitals

Scientific Research

Digital Pathology Scanner and Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Pathology Scanner and Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digital Pathology Scanner and Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Pathology Scanner and Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Digital Pathology Scanner and Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Digital Pathology Scanner and Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digital Pathology Scanner and Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Digital Pathology Scanner and Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Scanner Major Player Table 3. Software Major Player Table 4. Global Digital Pathology Scanner and Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Player Table 6. Scientific Research Major Player Table 7. Digital Pathology Scanner and Software Industry Trends Table 8. Digital Pathology Scanner and Software Industry Drivers Table 9. Digital Pathology Scanner and Software Industry Opportunities and Challenges Table 10. Digital Pathology Scanner and Software Industry Restraints Table 11. Global Digital Pathology Scanner and Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Digital Pathology Scanner and Software Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Digital Pathology Scanner and Software Market Share by Region (2021-2026) Table 14. Global Digital Pathology Scanner and Software Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Digital Pathology Scanner and Software Market Share by Region (2027-2032) Table 16. Global Digital Pathology Scanner and Software Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Digital Pathology Scanner and Software Revenue Market Share by Players (2021-2026) Table 18. Global Digital Pathology Scanner and Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Digital Pathology Scanner and Software Key Players Headquarters & Area Served Table 20. Global Digital Pathology Scanner and Software Players, Product Type & Application Table 21. Global Digital Pathology Scanner and Software Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Digital Pathology Scanner and Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Digital Pathology Scanner and Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Digital Pathology Scanner and Software Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Digital Pathology Scanner and Software Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Digital Pathology Scanner and Software Revenue Market Share by Type (2021-2026) Table 28. Global Digital Pathology Scanner and Software Revenue Market Share by Type (2027-2032) Table 29. Global Digital Pathology Scanner and Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Digital Pathology Scanner and Software Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Digital Pathology Scanner and Software Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Digital Pathology Scanner and Software Revenue Market Share by Application (2021-2026) Table 33. Global Digital Pathology Scanner and Software Revenue Market Share by Application (2027-2032) Table 34. Danaher Corporation Company Information Table 35. Danaher Corporation Business Overview Table 36. Danaher Corporation Digital Pathology Scanner and Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Danaher Corporation Digital Pathology Scanner and Software Product Portfolio Table 38. Danaher Corporation Recent Development Table 39. Fujifilm Company Information Table 40. Fujifilm Business Overview Table 41. Fujifilm Digital Pathology Scanner and Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Fujifilm Digital Pathology Scanner and Software Product Portfolio Table 43. Fujifilm Recent Development Table 44. Philips Healthcare Company Information Table 45. Philips Healthcare Business Overview Table 46. Philips Healthcare Digital Pathology Scanner and Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Philips Healthcare Digital Pathology Scanner and Software Product Portfolio Table 48. Philips Healthcare Recent Development Table 49. Mikroscan Company Information Table 50. Mikroscan Business Overview Table 51. Mikroscan Digital Pathology Scanner and Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Mikroscan Digital Pathology Scanner and Software Product Portfolio Table 53. Mikroscan Recent Development Table 54. 3DHISTECH Company Information Table 55. 3DHISTECH Business Overview Table 56. 3DHISTECH Digital Pathology Scanner and Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. 3DHISTECH Digital Pathology Scanner and Software Product Portfolio Table 58. 3DHISTECH Recent Development Table 59. PathAI Company Information Table 60. PathAI Business Overview Table 61. PathAI Digital Pathology Scanner and Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. PathAI Digital Pathology Scanner and Software Product Portfolio Table 63. PathAI Recent Development Table 64. Roche Company Information Table 65. Roche Business Overview Table 66. Roche Digital Pathology Scanner and Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Roche Digital Pathology Scanner and Software Product Portfolio Table 68. Roche Recent Development Table 69. Hamamatsu Photonics Company Information Table 70. Hamamatsu Photonics Business Overview Table 71. Hamamatsu Photonics Digital Pathology Scanner and Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Hamamatsu Photonics Digital Pathology Scanner and Software Product Portfolio Table 73. Hamamatsu Photonics Recent Development Table 74. Apollo Enterprise Imaging Company Information Table 75. Apollo Enterprise Imaging Business Overview Table 76. Apollo Enterprise Imaging Digital Pathology Scanner and Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Apollo Enterprise Imaging Digital Pathology Scanner and Software Product Portfolio Table 78. Apollo Enterprise Imaging Recent Development Table 79. XIFIN Company Information Table 80. XIFIN Business Overview Table 81. XIFIN Digital Pathology Scanner and Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. XIFIN Digital Pathology Scanner and Software Product Portfolio Table 83. XIFIN Recent Development Table 84. KFBIO Company Information Table 85. KFBIO Business Overview Table 86. KFBIO Digital Pathology Scanner and Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. KFBIO Digital Pathology Scanner and Software Product Portfolio Table 88. KFBIO Recent Development Table 89. Aiforia Company Information Table 90. Aiforia Business Overview Table 91. Aiforia Digital Pathology Scanner and Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Aiforia Digital Pathology Scanner and Software Product Portfolio Table 93. Aiforia Recent Development Table 94. Glencoe Software Company Information Table 95. Glencoe Software Business Overview Table 96. Glencoe Software Digital Pathology Scanner and Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Glencoe Software Digital Pathology Scanner and Software Product Portfolio Table 98. Glencoe Software Recent Development Table 99. North America Digital Pathology Scanner and Software Revenue by Type (2021-2026) & (US$ Million) Table 100. North America Digital Pathology Scanner and Software Revenue by Type (2027-2032) & (US$ Million) Table 101. North America Digital Pathology Scanner and Software Revenue by Application (2021-2026) & (US$ Million) Table 102. North America Digital Pathology Scanner and Software Revenue by Application (2027-2032) & (US$ Million) Table 103. North America Digital Pathology Scanner and Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. North America Digital Pathology Scanner and Software Revenue by Country (2021-2026) & (US$ Million) Table 105. North America Digital Pathology Scanner and Software Revenue by Country (US$ Million) & (2027-2032) Table 106. Europe Digital Pathology Scanner and Software Revenue by Type (2021-2026) & (US$ Million) Table 107. Europe Digital Pathology Scanner and Software Revenue by Type (2027-2032) & (US$ Million) Table 108. Europe Digital Pathology Scanner and Software Revenue by Application (2021-2026) & (US$ Million) Table 109. Europe Digital Pathology Scanner and Software Revenue by Application (2027-2032) & (US$ Million) Table 110. Europe Digital Pathology Scanner and Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Europe Digital Pathology Scanner and Software Revenue by Country (2021-2026) & (US$ Million) Table 112. Europe Digital Pathology Scanner and Software Revenue by Country (US$ Million) & (2027-2032) Table 113. China Digital Pathology Scanner and Software Revenue by Type (2021-2026) & (US$ Million) Table 114. China Digital Pathology Scanner and Software Revenue by Type (2027-2032) & (US$ Million) Table 115. China Digital Pathology Scanner and Software Revenue by Application (2021-2026) & (US$ Million) Table 116. China Digital Pathology Scanner and Software Revenue by Application (2027-2032) & (US$ Million) Table 117. Asia Digital Pathology Scanner and Software Revenue by Type (2021-2026) & (US$ Million) Table 118. Asia Digital Pathology Scanner and Software Revenue by Type (2027-2032) & (US$ Million) Table 119. Asia Digital Pathology Scanner and Software Revenue by Application (2021-2026) & (US$ Million) Table 120. Asia Digital Pathology Scanner and Software Revenue by Application (2027-2032) & (US$ Million) Table 121. Asia Digital Pathology Scanner and Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Asia Digital Pathology Scanner and Software Revenue by Region (US$ Million) & (2021-2026) Table 123. Asia Digital Pathology Scanner and Software Revenue by Region (US$ Million) & (2027-2032) Table 124. SAMEA Digital Pathology Scanner and Software Revenue by Type (2021-2026) & (US$ Million) Table 125. SAMEA Digital Pathology Scanner and Software Revenue by Type (2027-2032) & (US$ Million) Table 126. SAMEA Digital Pathology Scanner and Software Revenue by Application (2021-2026) & (US$ Million) Table 127. SAMEA Digital Pathology Scanner and Software Revenue by Application (2027-2032) & (US$ Million) Table 128. SAMEA Digital Pathology Scanner and Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. SAMEA Digital Pathology Scanner and Software Revenue by Country (2021-2026) & (US$ Million) Table 130. SAMEA Digital Pathology Scanner and Software Revenue by Country (US$ Million) & (2027-2032) Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Digital Pathology Scanner and Software Image Figure 2. Global Digital Pathology Scanner and Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digital Pathology Scanner and Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Scanner Image Figure 5. Software Image Figure 6. Global Digital Pathology Scanner and Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Digital Pathology Scanner and Software Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Scientific Research Image Figure 10. Global Digital Pathology Scanner and Software Market Size (US$ Million) & (2021-2032) Figure 11. Global Digital Pathology Scanner and Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Digital Pathology Scanner and Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Digital Pathology Scanner and Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Digital Pathology Scanner and Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Digital Pathology Scanner and Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Digital Pathology Scanner and Software Revenue Market Share by Type (2021-2032) Figure 18. Global Digital Pathology Scanner and Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Digital Pathology Scanner and Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Digital Pathology Scanner and Software Revenue Market Share by Application (2021-2032) Figure 21. North America Digital Pathology Scanner and Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Digital Pathology Scanner and Software Revenue Share by Type (2021-2032) Figure 23. North America Digital Pathology Scanner and Software Revenue Share by Application (2021-2032) Figure 24. North America Digital Pathology Scanner and Software Revenue Share by Country (2021-2032) Figure 25. United States Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Digital Pathology Scanner and Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Digital Pathology Scanner and Software Revenue Share by Type (2021-2032) Figure 30. Europe Digital Pathology Scanner and Software Revenue Share by Application (2021-2032) Figure 31. Europe Digital Pathology Scanner and Software Revenue Share by Country (2021-2032) Figure 32. Germany Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Digital Pathology Scanner and Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Digital Pathology Scanner and Software Revenue Share by Type (2021-2032) Figure 42. China Digital Pathology Scanner and Software Revenue Share by Application (2021-2032) Figure 43. Asia Digital Pathology Scanner and Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Digital Pathology Scanner and Software Revenue Share by Type (2021-2032) Figure 45. Asia Digital Pathology Scanner and Software Revenue Share by Application (2021-2032) Figure 46. Asia Digital Pathology Scanner and Software Revenue Share by Region (2021-2032) Figure 47. Japan Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Digital Pathology Scanner and Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Digital Pathology Scanner and Software Revenue Share by Type (2021-2032) Figure 55. SAMEA Digital Pathology Scanner and Software Revenue Share by Application (2021-2032) Figure 56. SAMEA Digital Pathology Scanner and Software Revenue Share by Country (2021-2032) Figure 57. Brazil Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Digital Pathology Scanner and Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Scanner
  • Software
Applications
  • Hospitals
  • Scientific Research
Companies covered
  • Danaher Corporation
  • Fujifilm
  • Philips Healthcare
  • Mikroscan
  • 3DHISTECH
  • PathAI
  • Roche
  • Hamamatsu Photonics
  • Apollo Enterprise Imaging
  • XIFIN
  • KFBIO
  • Aiforia
  • Glencoe Software

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Digital Pathology Scanner and Software Market by Type
  3. 1.2.1 Global Digital Pathology Scanner and Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Scanner
  5. 1.2.3 Software
  6. 1.3 Digital Pathology Scanner and Software Market by Application
  7. 1.3.1 Global Digital Pathology Scanner and Software Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Scientific Research
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Digital Pathology Scanner and Software Market Dynamics
  1. 2.1 Digital Pathology Scanner and Software Industry Trends
  2. 2.2 Digital Pathology Scanner and Software Industry Drivers
  3. 2.3 Digital Pathology Scanner and Software Industry Opportunities and Challenges
  4. 2.4 Digital Pathology Scanner and Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Digital Pathology Scanner and Software Market Perspective (2021-2032)
  2. 3.2 Global Digital Pathology Scanner and Software Growth Trends by Region
  3. 3.2.1 Global Digital Pathology Scanner and Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Digital Pathology Scanner and Software Market Size by Region (2021-2026)
  5. 3.2.3 Global Digital Pathology Scanner and Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Digital Pathology Scanner and Software Revenue by Players
  2. 4.1.1 Global Digital Pathology Scanner and Software Revenue by Players (2021-2026)
  3. 4.1.2 Global Digital Pathology Scanner and Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Digital Pathology Scanner and Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Digital Pathology Scanner and Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Digital Pathology Scanner and Software Key Players Headquarters & Area Served
  7. 4.4 Global Digital Pathology Scanner and Software Players, Product Type & Application
  8. 4.5 Global Digital Pathology Scanner and Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Digital Pathology Scanner and Software Market CR5 and HHI
  11. 4.6.3 2025 Digital Pathology Scanner and Software Tier 1, Tier 2, and Tier 3
5 Digital Pathology Scanner and Software Market Size by Type
  1. 5.1 Global Digital Pathology Scanner and Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Digital Pathology Scanner and Software Revenue by Type (2021-2032)
  3. 5.3 Global Digital Pathology Scanner and Software Revenue Market Share by Type (2021-2032)
6 Digital Pathology Scanner and Software Market Size by Application
  1. 6.1 Global Digital Pathology Scanner and Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Digital Pathology Scanner and Software Revenue by Application (2021-2032)
  3. 6.3 Global Digital Pathology Scanner and Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Danaher Corporation
  2. 7.1.1 Danaher Corporation Company Information
  3. 7.1.2 Danaher Corporation Business Overview
  4. 7.1.3 Danaher Corporation Digital Pathology Scanner and Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Danaher Corporation Digital Pathology Scanner and Software Product Portfolio
  6. 7.1.5 Danaher Corporation Recent Developments
  7. 7.2 Fujifilm
  8. 7.2.1 Fujifilm Company Information
  9. 7.2.2 Fujifilm Business Overview
  10. 7.2.3 Fujifilm Digital Pathology Scanner and Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Fujifilm Digital Pathology Scanner and Software Product Portfolio
  12. 7.2.5 Fujifilm Recent Developments
  13. 7.3 Philips Healthcare
  14. 7.3.1 Philips Healthcare Company Information
  15. 7.3.2 Philips Healthcare Business Overview
  16. 7.3.3 Philips Healthcare Digital Pathology Scanner and Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Philips Healthcare Digital Pathology Scanner and Software Product Portfolio
  18. 7.3.5 Philips Healthcare Recent Developments
  19. 7.4 Mikroscan
  20. 7.4.1 Mikroscan Company Information
  21. 7.4.2 Mikroscan Business Overview
  22. 7.4.3 Mikroscan Digital Pathology Scanner and Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Mikroscan Digital Pathology Scanner and Software Product Portfolio
  24. 7.4.5 Mikroscan Recent Developments
  25. 7.5 3DHISTECH
  26. 7.5.1 3DHISTECH Company Information
  27. 7.5.2 3DHISTECH Business Overview
  28. 7.5.3 3DHISTECH Digital Pathology Scanner and Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 3DHISTECH Digital Pathology Scanner and Software Product Portfolio
  30. 7.5.5 3DHISTECH Recent Developments
  31. 7.6 PathAI
  32. 7.6.1 PathAI Company Information
  33. 7.6.2 PathAI Business Overview
  34. 7.6.3 PathAI Digital Pathology Scanner and Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 PathAI Digital Pathology Scanner and Software Product Portfolio
  36. 7.6.5 PathAI Recent Developments
  37. 7.7 Roche
  38. 7.7.1 Roche Company Information
  39. 7.7.2 Roche Business Overview
  40. 7.7.3 Roche Digital Pathology Scanner and Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Roche Digital Pathology Scanner and Software Product Portfolio
  42. 7.7.5 Roche Recent Developments
  43. 7.8 Hamamatsu Photonics
  44. 7.8.1 Hamamatsu Photonics Company Information
  45. 7.8.2 Hamamatsu Photonics Business Overview
  46. 7.8.3 Hamamatsu Photonics Digital Pathology Scanner and Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Hamamatsu Photonics Digital Pathology Scanner and Software Product Portfolio
  48. 7.8.5 Hamamatsu Photonics Recent Developments
  49. 7.9 Apollo Enterprise Imaging
  50. 7.9.1 Apollo Enterprise Imaging Company Information
  51. 7.9.2 Apollo Enterprise Imaging Business Overview
  52. 7.9.3 Apollo Enterprise Imaging Digital Pathology Scanner and Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Apollo Enterprise Imaging Digital Pathology Scanner and Software Product Portfolio
  54. 7.9.5 Apollo Enterprise Imaging Recent Developments
  55. 7.10 XIFIN
  56. 7.10.1 XIFIN Company Information
  57. 7.10.2 XIFIN Business Overview
  58. 7.10.3 XIFIN Digital Pathology Scanner and Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 XIFIN Digital Pathology Scanner and Software Product Portfolio
  60. 7.10.5 XIFIN Recent Developments
  61. 7.11 KFBIO
  62. 7.11.1 KFBIO Company Information
  63. 7.11.2 KFBIO Business Overview
  64. 7.11.3 KFBIO Digital Pathology Scanner and Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 KFBIO Digital Pathology Scanner and Software Product Portfolio
  66. 7.11.5 KFBIO Recent Developments
  67. 7.12 Aiforia
  68. 7.12.1 Aiforia Company Information
  69. 7.12.2 Aiforia Business Overview
  70. 7.12.3 Aiforia Digital Pathology Scanner and Software Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Aiforia Digital Pathology Scanner and Software Product Portfolio
  72. 7.12.5 Aiforia Recent Developments
  73. 7.13 Glencoe Software
  74. 7.13.1 Glencoe Software Company Information
  75. 7.13.2 Glencoe Software Business Overview
  76. 7.13.3 Glencoe Software Digital Pathology Scanner and Software Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Glencoe Software Digital Pathology Scanner and Software Product Portfolio
  78. 7.13.5 Glencoe Software Recent Developments
8 North America
  1. 8.1 North America Digital Pathology Scanner and Software Revenue (2021-2032)
  2. 8.2 North America Digital Pathology Scanner and Software Revenue by Type (2021-2032)
  3. 8.2.1 North America Digital Pathology Scanner and Software Revenue by Type (2021-2026)
  4. 8.2.2 North America Digital Pathology Scanner and Software Revenue by Type (2027-2032)
  5. 8.3 North America Digital Pathology Scanner and Software Revenue Share by Type (2021-2032)
  6. 8.4 North America Digital Pathology Scanner and Software Revenue by Application (2021-2032)
  7. 8.4.1 North America Digital Pathology Scanner and Software Revenue by Application (2021-2026)
  8. 8.4.2 North America Digital Pathology Scanner and Software Revenue by Application (2027-2032)
  9. 8.5 North America Digital Pathology Scanner and Software Revenue Share by Application (2021-2032)
  10. 8.6 North America Digital Pathology Scanner and Software Revenue by Country
  11. 8.6.1 North America Digital Pathology Scanner and Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Digital Pathology Scanner and Software Revenue by Country (2021-2026)
  13. 8.6.3 North America Digital Pathology Scanner and Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Digital Pathology Scanner and Software Revenue (2021-2032)
  2. 9.2 Europe Digital Pathology Scanner and Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe Digital Pathology Scanner and Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe Digital Pathology Scanner and Software Revenue by Type (2027-2032)
  5. 9.3 Europe Digital Pathology Scanner and Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe Digital Pathology Scanner and Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe Digital Pathology Scanner and Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe Digital Pathology Scanner and Software Revenue by Application (2027-2032)
  9. 9.5 Europe Digital Pathology Scanner and Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe Digital Pathology Scanner and Software Revenue by Country
  11. 9.6.1 Europe Digital Pathology Scanner and Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Digital Pathology Scanner and Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe Digital Pathology Scanner and Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Digital Pathology Scanner and Software Revenue (2021-2032)
  2. 10.2 China Digital Pathology Scanner and Software Revenue by Type (2021-2032)
  3. 10.2.1 China Digital Pathology Scanner and Software Revenue by Type (2021-2026)
  4. 10.2.2 China Digital Pathology Scanner and Software Revenue by Type (2027-2032)
  5. 10.3 China Digital Pathology Scanner and Software Revenue Share by Type (2021-2032)
  6. 10.4 China Digital Pathology Scanner and Software Revenue by Application (2021-2032)
  7. 10.4.1 China Digital Pathology Scanner and Software Revenue by Application (2021-2026)
  8. 10.4.2 China Digital Pathology Scanner and Software Revenue by Application (2027-2032)
  9. 10.5 China Digital Pathology Scanner and Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Digital Pathology Scanner and Software Revenue (2021-2032)
  2. 11.2 Asia Digital Pathology Scanner and Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia Digital Pathology Scanner and Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia Digital Pathology Scanner and Software Revenue by Type (2027-2032)
  5. 11.3 Asia Digital Pathology Scanner and Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia Digital Pathology Scanner and Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia Digital Pathology Scanner and Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia Digital Pathology Scanner and Software Revenue by Application (2027-2032)
  9. 11.5 Asia Digital Pathology Scanner and Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia Digital Pathology Scanner and Software Revenue by Country
  11. 11.6.1 Asia Digital Pathology Scanner and Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Digital Pathology Scanner and Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia Digital Pathology Scanner and Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Digital Pathology Scanner and Software Revenue (2021-2032)
  2. 12.2 SAMEA Digital Pathology Scanner and Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Digital Pathology Scanner and Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Digital Pathology Scanner and Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA Digital Pathology Scanner and Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Digital Pathology Scanner and Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Digital Pathology Scanner and Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Digital Pathology Scanner and Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA Digital Pathology Scanner and Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Digital Pathology Scanner and Software Revenue by Country
  11. 12.6.1 SAMEA Digital Pathology Scanner and Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Digital Pathology Scanner and Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Digital Pathology Scanner and Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst